Intranasal Administration of the TLR2 Agonist Pam2Cys Provides Rapid Protection against Influenza in Mice
- 3 August 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 9 (9), 2710-2718
- https://doi.org/10.1021/mp300257x
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- IFN-γ Treatment at Early Stages of Influenza Virus Infection Protects Mice from Death in a NK Cell-Dependent MannerJournal of Interferon & Cytokine Research, 2010
- Neutrophils Ameliorate Lung Injury and the Development of Severe Disease during Influenza InfectionThe Journal of Immunology, 2009
- Lipid-containing mimetics of natural triggers of innate immunity as CTL-inducing influenza vaccinesInternational Immunology, 2006
- Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1Nature Immunology, 2006
- A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responsesProceedings of the National Academy of Sciences of the United States of America, 2004
- Highly Immunogenic and Totally Synthetic Lipopeptides as Self-Adjuvanting Immunocontraceptive VaccinesThe Journal of Immunology, 2002
- Inhibitory Role of Neutrophils on Influenza Virus Multiplication in the Lungs of MiceMicrobiology and Immunology, 2001
- Discrimination of bacterial lipoproteins by Toll-like receptor 6International Immunology, 2001
- Isolation, Structure Elucidation, and Synthesis of a Macrophage Stimulatory Lipopeptide from Mycoplasma fermentans Acting at Picomolar ConcentrationThe Journal of Experimental Medicine, 1997
- Protective Mechanisms against Pulmonary Infection with Influenza Virus. I. Relative Contribution of Polymorphonuclear Leukocytes and of Alveolar Macrophages to Protection during the Early Phase of Intranasal InfectionJournal of General Virology, 1987